The Coalition of Rheumatology Educators (CORE) initiative is designed to enhance rheumatologists’ awareness of the need for early diagnosis and aggressive management of rheumatoid arthritis (RA) and to better objectify assessment of disease activity, potentially leading to remission. Clinical experts in the field of rheumatology are working with Princeton CME and the American Academy of CME, Inc to develop educational content based on the latest published and presented data on early RA diagnosis and aggressive management, to incorporate that content into live, print, and Web-based CME programming, and to assess participant learning and ongoing educational needs.

Jointly Sponsored by the American Academy of CME, Inc and Princeton CME

Types of Credit

CME

Target Audience

This activity is designed for rheumatologists and physicians who manage patients with rheumatoid arthritis (RA).

Learning Objectives

After completing this activity, participants should be able to:

• Assess the potential benefits of early diagnosis and aggressive management of RA and related diseases, including the prospect of achieving remission
• Develop methods for properly evaluating remission in RA and related diseases, while altering management approaches based on therapeutic response

Grant Support

Supported by educational grants from Amgen Inc and Wyeth Pharmaceuticals (Tier 1), Bristol-Myers Squibb Company, Genentech, Inc, and Biogen Idec Inc (Tier 2), and Abbott Laboratories (Tier 3)